EUSA Pharma Archives -

UK-based EUSA Pharma has begun a late-stage trial of its antibody siltuximab in COVID-19, hoping that the IL-6

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where rivals failed

https://pharmaphorum.com/news/eusa-pharma-hopes-il-6-drug-will-work-in-covid-19-where-class-rivals-failed/

Digital/ News/ News

Record number of health firms feature in UK top 100 private tech list

Richard Staines Babylon Health, digital, EUSA Pharma, exscientia, Kymab 0 Comment

A record number of health and medtech companies have been included in the Sunday Times Sage Tech Track

Record number of health firms feature in UK top 100 private tech list

https://pharmaphorum.com/news/babylon-among/

News/ News/ Oncology

EUSA Pharma buys rights to Janssen rare disease drug

Richard Staines EUSA Pharma, M&A, Rare diseases 0 Comment

UK-based EUSA Pharma has bought worldwide rights to Janssen’s rare diseases drug Sylvant (siltuximab) for $115 million. EUSA

EUSA Pharma buys rights to Janssen rare disease drug

https://pharmaphorum.com/news/eusa-pharma-buys-rights-to-janssen-rare-disease-drug/

News/ News/ Oncology

Taking lenient stance, NICE backs neuroblastoma drug

Richard Staines dinutuximab alpha, EUSA Pharma, neuroblastoma, NICE 0 Comment

Body makes special case due to rarity of the disease

Taking lenient stance, NICE backs neuroblastoma drug

https://pharmaphorum.com/news/taking-lenient-stance-nice-backs-neuroblastoma-drug/

Cancer/ Market Access/ News/ News/ News/ News/ Oncology/ R&D

Fotivda approved in Scotland for kidney cancer

Piotr Wnuk EUSA Pharma, kidney cancer, Oncology 0 Comment

The Scottish Medicines Consortium (SMC) has recommended regular NHS funding for EUSA Pharma’s kidney cancer drug Fotivda, enabling

Fotivda approved in Scotland for kidney cancer

https://pharmaphorum.com/news/fotivda-scotland-kidney-cancer/

Market Access/ News/ News/ News/ Oncology

NICE asks EUSA pharma to drop price of neuroblastoma drug

Richard Staines cancer, EUSA Pharma, market access, NICE, Rare diseases 0 Comment

NICE calls for price cut before possible CDF funding

NICE asks EUSA pharma to drop price of neuroblastoma drug

https://pharmaphorum.com/news/nice-asks-eusa-pharma-to-drop-price-of-neuroblastoma-drug/

News/ UK & Europe

EUSA Pharma’s Fotivda approved in EU for kidney cancer

Richard Staines Bayer, cancer, EUSA Pharma, kidney cancer 0 Comment

UK pharma gets licence for second cancer drug

EUSA Pharma’s Fotivda approved in EU for kidney cancer

https://pharmaphorum.com/news/eusa-pharmas-fotivda-approved-eu-kidney-cancer/

News/ UK & Europe

EUSA Pharma looks to further in-licensing to build growth

Richard Staines cancer, EUSA Pharma, Jazz Pharmaceuticals, kidney cancer, neuroblastoma 0 Comment

Specialist company EUSA Pharma is looking for new medicines to develop after getting two cancer drugs recommended by European

EUSA Pharma looks to further in-licensing to build growth

https://pharmaphorum.com/news/uks-eusa-pharma-looks-bolster-pipeline/

News/ UK & Europe

Regulators finally back Merck KGaA oral MS drug

Richard Staines AbbVie, cancer, EUSA Pharma, Gilead, hepatitis C, Merck KGaA, multiple sclerosis, Samsung Bioepis 0 Comment

A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green

Regulators finally back Merck KGaA oral MS drug

https://pharmaphorum.com/news/regulators-mavenclad/

Trending

EUSA Pharma

Login